MedTrace Logo

Evaluation of Safety of Filler Injection in Subcutaneous Tissues

NCT06322043 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2025-09-23

No results posted yet for this study

Summary

Adipearl is an injectable filler intended to be injected subcutaneously.

Conditions

  • Face Volume Deficiency

Interventions

DEVICE

Adipearl

Injection of the investigational device in subcutaneous tissue.

Sponsors & Collaborators

  • Volumina Medical S.A.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-26
Primary Completion
2025-06-21
Completion
2025-10-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06322043 on ClinicalTrials.gov